- Home
- ALLR vs KITT Comparison
ALLR vs KITT Comparison
Compare ALLR & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- KITT
- Stock Information
- Founded
- ALLR 2004
- KITT 2014
- Country
- ALLR United States
- KITT United States
- Employees
- ALLR N/A
- KITT N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- KITT Industrial Machinery/Components
- Sector
- ALLR Health Care
- KITT Industrials
- Exchange
- ALLR Nasdaq
- KITT Nasdaq
- Market Cap
- ALLR 20.2M
- KITT 8.1M
- IPO Year
- ALLR N/A
- KITT N/A
- Fundamental
- Price
- ALLR $1.23
- KITT $1.40
- Analyst Decision
- ALLR Strong Buy
- KITT
- Analyst Count
- ALLR 1
- KITT 0
- Target Price
- ALLR $9.25
- KITT N/A
- AVG Volume (30 Days)
- ALLR 262.6K
- KITT 5.3M
- Earning Date
- ALLR 11-14-2025
- KITT 11-13-2025
- Dividend Yield
- ALLR N/A
- KITT N/A
- EPS Growth
- ALLR N/A
- KITT N/A
- EPS
- ALLR N/A
- KITT N/A
- Revenue
- ALLR N/A
- KITT $3,082,232.00
- Revenue This Year
- ALLR N/A
- KITT $2,936.06
- Revenue Next Year
- ALLR N/A
- KITT N/A
- P/E Ratio
- ALLR N/A
- KITT N/A
- Revenue Growth
- ALLR N/A
- KITT N/A
- 52 Week Low
- ALLR $0.61
- KITT $1.24
- 52 Week High
- ALLR $2.35
- KITT $54.36
- Technical
- Relative Strength Index (RSI)
- ALLR 40.99
- KITT 30.23
- Support Level
- ALLR $1.09
- KITT $1.24
- Resistance Level
- ALLR $1.45
- KITT $1.45
- Average True Range (ATR)
- ALLR 0.09
- KITT 0.32
- MACD
- ALLR -0.02
- KITT -0.04
- Stochastic Oscillator
- ALLR 37.42
- KITT 7.31
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.